立他司特2025年价格

Xiidra is a specific drug for the treatment of dry eye disease. In addition to being approved in the United States, the drug has also been approved in more than 30 countries including Canada, the European Union, and Japan. It has filled the gap in dry eye disease drugs that target the inflammatory pathway. Its price trend and medication specifications are of great significance to patients. This article will provide a detailed analysis of the price prediction, correct use method, and contraindication groups of this drug in 2025.

Ritalast price in 2025

It is a lymphocyte function-associated antigen-1 (LFA-1) antagonist for the treatment of dry eye disease. Its price is affected by patent protection and market demand.

U.S. market price

The specification of Ritalast produced by Shire Pharmaceuticals in the United States is 0.2ml*60 tubes/box. The price is expected to remain around US$547 in 2025. The price may fluctuate due to medical insurance policies.

Calculation of treatment cost

Standard usage is 2 times a day, 1 tube each time. Calculated based on a 30-day course of treatment, one box of medicine is required and costs approximately US$547. Patients with long-term use need to consider the cost of ongoing treatment.

Factors affecting price

Patent protection status, market competition and medical insurance coverage jointly determine the final price, and some insurance plans may cover part of the cost.

Before purchasing drugs, you should confirm the latest prices through formal channels and understand possible cost support policies.

Ritalast Medication Guide

The correct use of Ritalast is crucial to the therapeutic effect. The following operating instructions must be strictly followed.

How to use

Use a disposable container to instill 1 drop into each eye twice daily (approximately 12 hours apart). Discard container immediately after use for each eye to avoid cross-contamination.

Wearing contact lenses

Contact lenses need to be removed before administration, and wait 15 minutes after administration before wearing them again, which will help the drug to be fully absorbed and reduce the risk of irritation.

Administration Tips

When instilling the medicine, tilt the head back and gently pull the lower eyelid to form a pouch. Avoid contact of container tip with eyes or any surface to prevent contamination.

If multiple eye drops are used at the same time, there should be an interval of at least 5 minutes to ensure that each medicine is fully absorbed.

Contraindicated groups for Ritalast

The use of Ritalast in certain groups may increase the risk of adverse reactions. The following contraindications require special attention.

Patients with allergies

It is forbidden for those who are allergic to the ingredients of ritasilast. Before taking the medicine, the doctor should be informed of the history of drug allergies, especially allergies to eye drugs.

Patients with eye infection

It is contraindicated during active eye infection. The infection must be controlled first and use can only be started after being evaluated by a physician.

Special Populations

The safety of children under 18 years of age has not been established. Pregnant and lactating women should use it with caution and evaluate the benefit-risk ratio.

If serious eye irritation or vision changes occur during use, you should stop taking the medicine immediately and seek medical examination.